✦ LIBER ✦

788 Pretreatment clinical prognostic factors influencing survival in patients with stage III non-small cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy (HFX RT) with or without concurrent chemotherapy (CHT)

✍ Scribed by B. Jeremic; B. Millicic; A. Dagovic; S. Dagovic; J. Stankovic; J. Aleksandrovic; S. Bosnjakovic

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1051 Pretreatment prognostic factors in

✍ Jeremic, B.; Shibamoto, Y.; Acimovic, Lj.; Milisavljevic, S. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Hyperfractionated radiation therapy (HFX

✍ Jeremic, B.; Djuric, Lj.; Jevremovic, S.; Matovic, M.; Shibamoto, Y. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Hyperfractionated radiation therapy (HFX

✍ Jeremic, B.; Djuric, Lj.; Jevremovic, S.; Shibamoto, Y. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Pre-treatment prognostic factors in pati

✍ Jeremic, Branislav; Shibamoto, Yuta 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 604 KB

Pre-treatment prognostic factors in pati

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Hyperfractionated radiation therapy (Hfx

✍ Jeremic, B.; Milicic, B.; Milisavljavic, S. 📂 Article 📅 2013 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 177 KB